2021-01-07,Evelo Biosciences Expands Clinical Programs and Provides 2021 Guidance on Key Milestones
2020-12-23,"Benzinga's Top Upgrades, Downgrades For December 23, 2020"
2020-12-21,"Evelo Biosciences Appoints Industry Veteran Jonathan Zung, Ph.D. as Chief Development Officer"
2020-12-14,"Insider Buying: The Evelo Biosciences, Inc. (NASDAQ:EVLO) Independent Chairman Just Bought 77% More Shares"
2020-12-09,Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer
2020-12-09,Evelo Biosciences Reports Positive Topline Clinical Data in Phase 1b Trial of EDP1815 in Atopic Dermatitis
2020-12-03,Evelo Biosciences Completes Enrollment to Interim Target in Phase 2 Trial Evaluating EDP1815 for the Treatment of Psoriasis
2020-11-27,"Hedge Funds Are Dumping Evelo Biosciences, Inc. (EVLO)"
2020-11-10,"What You Need To Know About Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Investor Composition"
2020-11-09,Evelo Biosciences Presents New Preclinical Data for Anti-Tumor Effects of Orally Delivered Microbial Extracellular Vesicles at the SITC 35th Anniversary Annual Meeting
2020-10-29,Evelo Biosciences Reports Third Quarter 2020 Financial Results and Business Highlights
2020-10-29,"Evelo Biosciences, Inc. to Host Earnings Call"
2020-10-22,"Evelo Biosciences to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020"
2020-10-15,Evelo Biosciences to Host Key Opinion Leader Discussion Focused on the Unmet Need in Psoriasis and Atopic Dermatitis and the Potential Opportunity for EDP1815
2020-10-14,Evelo Biosciences Completes Enrollment in Phase 1b Clinical Trial Cohort Evaluating EDP1815 in Atopic Dermatitis
2020-10-13,Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis
2020-10-12,Evelo Biosciences (EVLO) Looks Good: Stock Adds 5.9% in Session
2020-09-14,Evelo Biosciences Appoints Julie Carretero as Chief People Officer
2020-09-08,Evelo Biosciences to Participate in Upcoming Investor Conferences in September
2020-07-30,Evelo Biosciences Reports Second Quarter 2020 Financial Results and Business Highlights
2020-07-23,"Evelo Biosciences to Report Second Quarter 2020 Financial Results on Thursday, July 30, 2020"
2020-07-07,Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
2020-07-01,Evelo Biosciences to Present Clinical Data from Phase 1/2 Trial of EDP1503 at the ESMO World Congress on Gastrointestinal Cancer Virtual Meeting
2020-06-24,Evelo Biosciences Announces Pricing of Public Offering of Common Stock
2020-06-24,Evelo Biosciences Announces Proposed Public Offering of Common Stock
2020-06-22,Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial
2020-06-16,Evelo Biosciences to Present at Virtual BMO 2020 Prescriptions for Success Healthcare Conference
2020-05-29,"Evelo Biosciences, Inc. (EVLO) Upgraded to Strong Buy: What Does It Mean for the Stock?"
2020-05-28,Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
2020-05-28,Evelo Biosciences to Present at Jefferies Virtual Healthcare Conference
2020-05-27,"Evelo Biosciences, Inc. (EVLO): Hedge Fund Sentiment Unchanged"
2020-05-27,Evelo Biosciences Sees Hammer Chart Pattern: Time to Buy?
2020-05-14,"Before You Buy Evelo Biosciences, Inc. (NASDAQ:EVLO), Consider Its Volatility"
2020-05-11,Evelo Biosciences Reports First Quarter Financial Results and Business Highlights
2020-05-07,"Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients"
2020-05-04,"Evelo Biosciences to Report First Quarter 2020 Financial Results on Monday, May 11, 2020"
2020-04-15,"Evelo Biosciences Appoints Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer"
2020-03-05,Evelo Announces Issuance of U.S. Patent Covering Use of Proprietary Bifidobacterium animalis ssp. lactis Strain for Treating Cancer
2020-03-02,Evelo Biosciences Announces Biomarker Data Showing EDP1815 is an Orally Delivered Dual Cytokine Inhibitor for Inflammatory Diseases
2020-02-25,Analysts: 3 Healthcare Stocks to Buy on Coronavirus Weakness
2020-02-25,Evelo Biosciences to Present at 40th Annual Cowen Health Care Conference
2020-02-13,Evelo Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
2020-02-06,"Evelo Biosciences to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020"
2020-01-10,Evelo Provides Update on Recent Positive EDP1815 Regulatory Interactions on Phase 2 Trial Design Resulting in Shorter Development Timeline to Registration
2019-12-20,"Hedge Funds Have Never Been This Bullish On Evelo Biosciences, Inc. (EVLO)"
2019-12-19,Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
2019-12-05,Evelo Biosciences Appoints Juan Andres to Board of Directors
2019-11-13,Evelo Biosciences to Present at the Stifel 2019 Healthcare Conference
2019-11-08,Evelo Biosciences to Present Preclinical Data from its EDP1503 Oncology Program at the Society for Immunotherapy of Cancers (SITC) Annual Meeting
2019-11-05,Evelo Biosciences Reports Further Positive EDP1815 Interim Clinical Data in Patients with Psoriasis at High Dose in Phase 1b Trial
2019-11-05,Evelo Biosciences Announces Further Positive Interim Phase 1b Clinical Data in Psoriasis and Reports Third Quarter 2019 Financial Results
2019-10-29,"Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, November 5th"
2019-09-26,Evelo Biosciences to Present at the 2019 Cantor Global Healthcare Conference
2019-09-20,Evelo Biosciences to Host Key Opinion Leader Symposium on Unmet Need in Mild to Moderate Psoriasis and Potential for EDP1815
2019-09-17,Evelo Biosciences Announces the Appointment of David Epstein as Chairman of its Board of Directors
2019-09-03,Evelo Biosciences to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
2019-08-06,"Evelo Biosciences, Inc. (EVLO) Q2 2019 Earnings Call Transcript"
2019-08-06,Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial
2019-08-06,Evelo Biosciences Announces Positive Interim Phase 1b Clinical Data and Provides Second Quarter 2019 Financial Results
2019-07-30,"Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, August 6th"
2019-07-25,Evelo Biosciences Secures $45 Million Debt Financing from K2 HealthVentures
2019-07-15,Kaleido Biosciences Announces Appointment of Theo Melas-Kyriazi to its Board of Directors
2019-05-30,Evelo Biosciences to Present at Upcoming Investor Conferences in June
2019-05-27,"Introducing Evelo Biosciences (NASDAQ:EVLO), The Stock That Slid 53% In The Last Year"
2019-05-15,Evelo Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
2019-05-08,"In slow year for life science IPOs, this venture firm is making big money"
2019-05-04,"Evelo Biosciences, Inc. (EVLO) Q1 2019 Earnings Call Transcript"
2019-05-02,Evelo Biosciences Reports First Quarter 2019 Financial Results and Recent Business Highlights
2019-04-25,"Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Thursday, May 2, 2019"
2019-04-03,Evelo Biosciences to Present at 18th Annual Needham Healthcare Conference
2019-03-04,Evelo Biosciences to Present at 39th Annual Cowen & Co. Health Care Conference
2019-02-14,Evelo Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
2019-02-07,"Evelo Biosciences to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, February 14, 2019"
2019-01-28,Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma
2019-01-04,Evelo Biosciences Announces Dosing of First Patient in Phase 1/2 Clinical Trial of EDP1503 in Combination with KEYTRUDA® (pembrolizumab) in Multiple Oncology Indications
2018-12-05,Evelo Biosciences to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
2018-11-27,Evelo Enters into Clinical Trial Collaboration Agreement with Merck
2018-11-26,Evelo Biosciences Announces First Dosing in Phase 1b Clinical Trial of EDP1815 in Psoriasis and Atopic Dermatitis
2018-11-13,"Report: Developing Opportunities within Evelo Biosciences, ADMA Biologics, Karyopharm Therapeutics, Pingtan Marine Enterprise, Rosetta Stone, and Williams Companies  Future Expectations, Projections Moving into 2018"
2018-11-07,Evelo Biosciences to Present at Upcoming Investor Conferences in November
2018-11-01,Evelo Biosciences Reports Third Quarter 2018 Financial Results and Recent Business Highlights
2018-09-06,Evelo Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
2018-08-02,Evelo Biosciences Reports Second Quarter 2018 Financial Results and Recent Business Highlights
2018-06-25,"Evelo Biosciences Added To Russell 3000®, 2000® and Microcap® Indexes"
2018-06-15,[$$] Verrica Pharma Adds to Drumbeat of Biotech IPOs
2018-06-14,Evelo Biosciences to Present at the JMP Securities 2018 Life Sciences Conference
2018-06-04,"Evelo Biosciences' Potential Is 'Significant,' Says Bullish Morgan Stanley"
2018-05-31,Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights
2018-05-11,Evelo Biosciences Announces Closing of Initial Public Offering
2018-05-10,[$$] Evelo Biosciences Shares Rise Slightly Post-IPO
2018-05-08,Evelo Biosciences Announces Pricing of Initial Public Offering
